NDC 11673-320 - Maximum Strength Daytime Severe and Nighttime Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-320
- Manufacturer
- TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2023-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 748L Maximum Strength Daytime Severe Nighttime Cold & Flu | TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2023-10-30 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Wellness Hemorrhoidal | MINERAL OIL, PETROLATUM, AND PHENYLEPHRINE HCL | Family Dollar Services, Inc | fe3293bc-80b5-b60a-e053-6394a90a4ede | 2025-10-22 | Warnings | 04JA59TNSJ |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | 39b8382a-e96d-462d-895f-27cbb9a305ec | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Bryant Ranch Prepack | 3e41e55f-7e41-4653-aadb-32a9e47962d9 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Amneal Pharmaceuticals of New York LLC | 62be4147-6a72-49e5-9338-10887c65a93a | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Amneal Pharmaceuticals of New York LLC | 683d563f-0686-4964-8183-cf08758cae71 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2025-10-22 | Warnings | 362O9ITL9D |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | PDC6A3C0OX |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | ac88fa99-625b-4854-a406-9e21a6b9c1c8 | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | TIME CAP LABS INC | 05364eb4-07a1-a4d9-e063-6294a90a47e5 | 2025-10-21 | Warnings | 362O9ITL9D |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy, Inc. | 6deb854f-863e-24ad-e053-2991aa0afb17 | 2025-10-21 | Warnings | 362O9ITL9D |
| BackAid | ACETAMINOPHEN, CAFFEINE | Kobayashi Healthcare International, Inc. | 25db6bb5-96b6-4be1-e063-6294a90a2300 | 2025-10-21 | Warnings | 362O9ITL9D |
| Rycontuss | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Dextrum Laboratories, Inc | 41afb883-1158-9764-e063-6294a90a1712 | 2025-10-21 | Warnings | 9D2RTI9KYH 04JA59TNSJ |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | AvPAK | 5174bd9a-b777-a6e3-f72f-c16082ee67d3 | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Guaifenesin and Dextromethorphan Hydrobromide | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Method Pharmaceuticals | 1538bf63-d020-3ba2-e063-6294a90aecc5 | 2025-10-21 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Guaifenesin and Dextromethorphan Hydrobromide | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Method Pharmaceuticals | 389230e5-775e-5b0d-e054-00144ff88e88 | 2025-10-21 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Guaifenesin | GUAIFENESIN | Method Pharmaceuticals, LLC | 1539c3d4-d982-7d4e-e063-6394a90ad7d6 | 2025-10-21 | Warnings | 495W7451VQ |
| Guaifenesin | GUAIFENESIN | Method Pharmaceuticals, LLC | 312ce620-4841-7488-e054-00144ff88e88 | 2025-10-21 | Warnings | 495W7451VQ |
| M-Dryl | DIPHENHYDRAMINE HYDROCHLORIDE | Method Pharmaceuticals, LLC | 5a60c923-8bb7-427f-9636-08ed5474f71b | 2025-10-21 | Warnings | TC2D6JAD40 |
| M-PAP | ACETAMINOPHEN | Method Pharmaceuticals, LLC | 1539dc44-15a0-153b-e063-6294a90a9d45 | 2025-10-21 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.